These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30628471)

  • 1. Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy.
    Zou M; Samiullah M; Xu P; Wang S; He J; Wu T; Luo F; Yan J
    J Drug Target; 2019 Sep; 27(8):885-895. PubMed ID: 30628471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Inspired Gold Nanorod-Mesoporous Silica Core-Shell Nanoparticles Integrated with tTF-EG3287 for Synergetic Tumor Photothermal Therapy and Selective Therapy for Vascular Thrombosis.
    Luo X; Xie J; Zhou Z; Ma S; Wang L; Li M; Liu J; Wang P; Li Y; Luo F; Yan J
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):44013-44027. PubMed ID: 34494427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
    Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and construction of a magnetic targeting pro-coagulant protein for embolic therapy of solid tumors.
    Zou M; Xu P; Wang L; Wang L; Li T; Liu C; Shi L; Xie J; Li W; Wang S; Wu G; Luo F; Wu T; Yan J
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):116-128. PubMed ID: 31852257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Li T; Liu C; Wang L; Wang L; Luo F; Wu T; Yan J
    Int J Oncol; 2019 Oct; 55(4):823-832. PubMed ID: 31432158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-Responsive Liposomes Loaded with Targeting Procoagulant Proteins as Potential Embolic Agents for Solid Tumor-Targeted Therapy.
    Wang L; Wang L; Xu P; Liu C; Wang S; Luo X; Li M; Liu J; Zhao Z; Lai W; Luo F; Yan J
    Mol Pharm; 2022 May; 19(5):1356-1367. PubMed ID: 35420039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth.
    Li S; Tian Y; Zhao Y; Zhang Y; Su S; Wang J; Wu M; Shi Q; Anderson GJ; Thomsen J; Zhao R; Ji T; Wang J; Nie G
    Oncotarget; 2015 Sep; 6(27):23523-32. PubMed ID: 26143637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion protein tTF-EG3287 induces occlusion of tumor vessels and impairs tumor growth in human colon caner.
    Qiu GQ; Xie X; Zhao B; Xu LZ; Chen YQ
    Neoplasma; 2019 Mar; 66(2):252-260. PubMed ID: 30569722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
    Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
    Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
    J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.
    Zhao L; Chen H; Lu L; Zhao C; Malichewe CV; Wang L; Guo X; Zhang X
    Life Sci; 2021 Apr; 270():119113. PubMed ID: 33508290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.
    Jia H; Bagherzadeh A; Hartzoulakis B; Jarvis A; Löhr M; Shaikh S; Aqil R; Cheng L; Tickner M; Esposito D; Harris R; Driscoll PC; Selwood DL; Zachary IC
    J Biol Chem; 2006 May; 281(19):13493-13502. PubMed ID: 16513643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
    Chen X; Lv H; Ye M; Wang S; Ni E; Zeng F; Cao C; Luo F; Yan J
    Int J Pharm; 2012 Apr; 426(1-2):248-255. PubMed ID: 22310463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction.
    Shi Q; Zhang Y; Liu S; Liu G; Xu J; Zhao X; Anderson GJ; Nie G; Li S
    Biochem Pharmacol; 2018 Oct; 156():501-510. PubMed ID: 30222966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.
    Kim JY; Han JH; Park G; Seo YW; Yun CW; Lee BC; Bae J; Moon AR; Kim TH
    Oncotarget; 2016 May; 7(22):32449-61. PubMed ID: 27083053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
    Bieker R; Kessler T; Schwöppe C; Padró T; Persigehl T; Bremer C; Dreischalück J; Kolkmeyer A; Heindel W; Mesters RM; Berdel WE
    Blood; 2009 May; 113(20):5019-27. PubMed ID: 19179306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
    Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
    ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.
    Barr MP; Byrne AM; Duffy AM; Condron CM; Devocelle M; Harriott P; Bouchier-Hayes DJ; Harmey JH
    Br J Cancer; 2005 Jan; 92(2):328-33. PubMed ID: 15655556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.